Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

General discussion, page-8244

First 8244 Last

ma420

6,631 Posts.

1670

28/09/21

23:02

Post #: 56418946

Originally posted by malkazoid: ↑
"In particular, we estimate that such funds, together with such existing cash, will be sufficient to enable us to advance our
clinical trials to the point where all programs have completed pivotal Phase 2 trials or two programs have
completed pivotal Phase 2 trials and one program completed a Phase 3 clinical trial. The specifics of which
trials are progressed first will depend on clinical success. At this stage we anticipate that the OSA, RA and IBD
will advance the quickest. Funds for additional Phase 3 trials will be raised through future capital raises. It is
estimated that completion of all six clinical development programs will cost approximately A$200 million."

-------------------

I love this part.
Confirmation that OSA, Rheumatoid Arthritis and IBD will probably push through the stages fastest. I suspected RA would go quickly considering IHL675a is basically a vastly improved version of an existing approved and standard treatment for the affliction.

Also great to see a ballpark cost for all trials. I have full confidence they will find ample funding for these along the way: investors and potential partners will take note of the massive market potential and de-risked nature of these pathways.
Expand

Originally posted by thevinnys: ↑
NEW PATENTS UPDATES

Major Change here in the Amended Filing
As of 20 September, 2021, we added 5 new patent applications to our portfolio: PCT/AU2020/051056, PCT/AU2021/050226, PCT/AU2021/050734, Australian Provisional Patent Application No. AU 2021902170, and Australian Provisional Patent Application No. AU 2021902426.
Patent Portfolio
The following table presents our portfolio of patents and patent applications, including their status (as at 20 September, 2021) and title.
Patent Family
Title
Status
Expires
1
PCT/AU2020/051056
Compositions for the treatment or prevention of traumatic brain injury
Pending
02/10/2040*
2
PCT/AU2021/050226
Methods and compositions for treating or preventing an inflammatory condition
Pending
15/03/2041*
3
PCT/AU2021/050734
Compositions and methods for the treatment of obstructive sleep apnoea (OSA)
Pending
09/07/2041*
4
AU 2021902170
A composition and uses thereof
Pending (Provisional)
14/07/2042^*
5
AU 2021902426
A method of treatment
Pending (Provisional)
04/08/2042^*

Complete new update from original filing
Expand
I posted similar screenshots in the US listing thread not seeing this before. Good luck guys.

IHL Price at posting: 36.0¢ Sentiment: Buy Disclosure: Held

0 Great analysis

Top Stories

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

RCE

Recce's R327 found effective against E.coli during clinical trial

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

There are more pages in this discussion • 11,653 more messages in this thread...

First 8244 Last

Add IHL (ASX) to my watchlist

SPONSORED BY